Clinical Trial Update: Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing predictors of treatment response to aflibercept and aqueous cytokine levels in diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED